After DEA Administrator Anne Milgram selected 25 witnesses to participate in the hearing that’s set to commence on December 2, there was pushback from certain advocates and stakeholders who requested to join but were ultimately denied. MedPharm was among those denied the opportunity to weigh in. In response, MedPharm, a DEA-registered research firm, filed a motion to intervene. It asked the DEA administrative law judge (ALJ) overseeing the hearing to allow it to join despite the administrator’s denial. A Must Read Article: https://lnkd.in/gTdu-_k5 #reschedulingmarijuana #reschedulingcannabis #cannabisresearch #cannabisadvocates #marijuana #marijuanahearings #dea
